Some pharmacological properties of a newly synthesized 3-acetoxy-6β-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95)

Archives Internationales de Pharmacodynamie et de Therapie

Volumn 331, Issue 2, 1996, Pages 136-152

  Hosoki, R ^a   Niizawa, S ^a   Koike, K ^a   Sagara, T ^a   Kanematsu, K ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KT 90; LEUCINE ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NEW DRUG; NORBINALTORPHIMINE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENCY; DRUG SYNTHESIS; ELECTROSTIMULATION; FEMALE; GUINEA PIG; ILEUM; MALE; MOUSE; MUSCLE TWITCH; NONHUMAN; RABBIT; RAT; RECEPTOR BINDING; SMOOTH MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION; VAS DEFERENS; WRITHING TEST;

ANALGESIA; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; GUINEA PIGS; LETHAL DOSE 50; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; RABBITS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES; VAS DEFERENS;

EID: 0029825308     PISSN: 00039780     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ARUNI.AKSIIANA, O. and SCHILD, H. O. Some quantitative uses of drug antagonists. Brit. J. Plmrnuicol. 14, 48-58 (1959).
2. CHAVKIN, C., JAMES, I. F. and GOLDSTEIN, A. Dynorphin is a specific endogenous ligand of the K'-opioid receptor. Science 215, 413-415 (1982).
3. COTMAN, C. W. and MATTHEWS, D. A. Synaptic plasma membranes from rat brain synaptosomes: Isolation and partial characterization. Biochem. biophys. Ada 249, 380-394 (1971).
4. FINNEY, D. J. Graphical estimation of relative potency [in biological assays] from quantal responses. J. Pharmacol. e.\p. Tlier. 104, 440-444 (1952).
5. HAYES, A. and KELLY, A. Profile of activity of kappa receptor agonists in the rabbit vas deferens. Eiirop. J. Pharmacol. 110, 317-322 ( 1985 ).
6. KOIKE, K., TAKAYANAGI, I., HIRAKURA, Y. and MATSUEDA, R. Irreversible blockade of the A'-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group. Arch. int. Phannacoilyn. 313, 33-46 (1991).
7. KONNO, F., SATO, Y., TOGASHI, Y., TAKAYANAGI, I. and HIROBE, M. Interactions of codeine7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors. Gen. Pharmacol. 16, 379-381 (1985).
8. KONNO, F., KOBAYASIII, C., MORIMOTO, R., TAKAYANAGI, I., Cno, N. and HIROBC, M. Pharmacological effects of nalorphine and nalorphine-7,8-o.xide (nalorphine-epoxide): Interaction of the intrinsic activity, affinity and pharmacological responses. Arch. int. Phtmnacodyn. 282, 219-232 (1986).
9. KOSTERLITZ, H. K. and WATERFIELU, A. A. In vitro models in the study of structure-activity relationships of narcotic analgesics. Anmi. Rev. Pharmacol. 15, 29-417 (1975).
10. KOVâCS, G., NYOLCZAS, N., KRIVâN, M. and GULYA, K. Analgesic and tolerance-inducing effects of the high selective (5-opioid agonist [D-Phen2, D-Phen5]enkephalin in mice. Europ. J. Pharmacol. 150, 347-353 (1988).
11. LITCHFIELD, J. T. and WILCOXON, F. A. A simplified method of evaluating dose-effect experiments. J. Pharmacol. exp. Tlwr. 96, 99-113 (1949).
12. LORD, J. A. H., WATEKHKI.D, A. A., HUGHES, J. and KOSILRUFJ., H. W. Endogenous opioid peptides: Multiple agonists and receptors. Nature 267, 495-499 (1977).
13. LOWRY, O. H., ROSëHROUGII, N. J., FARR, A. L. and RANUAI.I., R. U. Protein measurement with the Polin phenol reagent. J. biol. Chem. 193, 265-275 (1951).
14. MAGNAN, J., PATKRSON, S. L., TAVANI, A. and KOSTERUT/, H. W. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. NaiinynSchmiedebergs Arch. Phanmicol. 319, 197-205 (1982).
15. MARTIN, W. R., HADES, C. G., THOMPSON, J. A., HUPPI.ER, R. E. and Gn.nrRT, P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dogs. J. Phannacol. t:\-p. Ther. 197, 512-532 (1976).
16. MII.I.AN, M. J. /i'-Opioid receptors and analgesia. Trends pharmacol. Sci. 11, 70-76 (1990).
17. OKA, T., Nir.isiii, K., SUDA, M., MATSUMIYA, T., INAJ.U, T. and UEKI, M. Rabbit vas déferons: A specific bioassay for opioid kappa-receptor agonists. Etirop. J. Phanmicol. 73, 235-236(1981).
18. PORRI:CA, F., MOSBERG, H. I., HURST, R., HRUBY, V. J. and BURKS, T. F. Role of mu, delta and kappa opioid receptors in spinal cord and supraspinal mediation of gastrointestinal transit eITects and hot-plate analgesia in the mouse. J. Pharmacol. exp. Ther. 230, 341-348(1984).
19. PORTUGUESE, P. S., LIPKOWSKI, A. W. and TAKEMORI, A. E. Binaltorphiminc and norbinaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40, 1287-1292 (1987).
20. RANDAI.I., L. O. and SEIJTTO, J. J. A method for measurement of analgesic activity on inflamed tissue. Arch. int. Pliannacoilyn. Ill, 409-419 (1957).
21. SAGARA, T., OJ.AWA, S., KUSIIIYAMA, E., KOIKE, K., TAKAYANACM, I. and KANEMATSU, K. Design and synthesis of 10-oxo derivative of A'-cyclopropylmethyl (-)-6/?-acetyllhiodihydronormorphine, a potentially selective opioid receptor ligand. Bioorg. mt'tl. Chcni. Lett. 5, 1505-1508 (1995).
22. SIMANTOV, R., GUILDER, S. R. and SNIDER, S. H. The opiate receptor binding interactions of [3II]methioninc cnkcphalin, an opioid peptide. Enrop. J. Pharmacol. 47, 319-331 (1978).
23. TAKAYANAGI, I., OKUMURA, K., KONNO, F., KOIKE, K., Clio, N. and HIROBI:, M. Intrinsic activity and effects of guanyl-5'-yl imidophosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalo.xone and morphine-7,8-o.\ide to kappa-receptor. Gen. Pharmacol. 16, 617-619 (1985).
24. TAKAYANAGI, I., GOROMARU, N., KOIKE, K., KONNO, F., MURI, T., YOSIIIDA, M. and KANEMATSU, K. Interaction of newly synthesized A'-cyclopropylmethyl derivatives of (-)-6/?-acetylthionormorphine with opioid receptors. Gen. Pharmacol. 21, 541-546 (1990).
25. TAKEMORI, A. 0., Ho, B. Y., NAESETH, J. S. and PORTUGUESE, P. S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. cxp. Ther. 246, 255-258 (1988).
26. VAN ROSSUM, J. M. Cumulative dose-response curves. II. Techniques for the making of dose-response curves in isolated organs and evaluation of drug parameters. Arch. int. Pharmacodyn. 143, 299-330 (1963).
27. WARD, S. J. and TAKEMOKI, A. E. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J. Pharmacol. exp. Ther. 224, 525-530 (1983).